Casdatifan plus Cabometyx showed promising activity and tolerability in clear cell renal cell carcinoma patients in the ARC-20 trial. Welireg dosing regimens demonstrated varying response rates, with ...

Among modern cancer therapies, immune checkpoint inhibitors (ICI) are among the most successful treatment methods. These ...

Clear cell odontogenic carcinoma (CCOC) is a rare malignant neoplasm of odontogenic origin that predominantly affects the jawbones, particularly the mandible. Typically presenting in middle-aged to ...

CAR T-cell therapy is being adapted for clear cell renal cell carcinoma, targeting CAIX and CD70 to improve efficacy and safety. Early trials like COBALT-RCC and TRAVERSE show promising disease ...

Gynecologic clear cell cancers are aggressive malignant neoplasms with low response rates to chemotherapy. Among patients with advanced clear cell ovarian and endometrial cancers who received ...

Select patients with oligometastatic ccRCC might be managed with a period of metastasis-directed therapy alone. Serial metastasis-directed radiation therapy may delay systemic therapy in clear cell ...

Anlotinib plus everolimus as first-line treatment for advanced non–clear cell renal cell carcinoma: 1 year updated results from UC-001, a single-center, single-arm, phase II trial. This is an ASCO ...